Metastatic Breast Cancer: Subgroup Analyses of the German non-Intervention Study

被引：0
作者：
不详
机构：
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2013年 / 51卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A7 / A7
页数：1
相关论文
共 4 条
[1]   Independent Review of E2100: A Phase III Trial of Bevacizumab Plus Paclitaxel Versus Paclitaxel in Women With Metastatic Breast Cancer [J].
Gray, Robert ;
Bhattacharya, Suman ;
Bowden, Christopher ;
Miller, Kathy ;
Comis, Robert L. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (30) :4966-4972
[2]   Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer [J].
Miles, David W. ;
Chan, Arlene ;
Dirix, Luc Y. ;
Cortes, Javier ;
Pivot, Xavier ;
Tomczak, Piotr ;
Delozier, Thierry ;
Sohn, Joo Hyuk ;
Provencher, Louise ;
Puglisi, Fabio ;
Harbeck, Nadia ;
Steger, Guenther G. ;
Schneeweiss, Andreas ;
Wardley, Andrew M. ;
Chlistalla, Andreas ;
Romieu, Gilles .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) :3239-3247
[3]   RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative, Locally Recurrent or Metastatic Breast Cancer [J].
Robert, Nicholas J. ;
Dieras, Veronique ;
Glaspy, John ;
Brufsky, Adam M. ;
Bondarenko, Igor ;
Lipatov, Oleg N. ;
Perez, Edith A. ;
Yardley, Denise A. ;
Chan, Stephen Y. T. ;
Zhou, Xian ;
Phan, See-Chun ;
O'Shaughnessy, Joyce .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (10) :1252-1260
[4]  
Schrader I, ASCO 2012
1